Search

everythinglearnresearchcommunity

for

Search:↓

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

Antiepileptic drugs can cause cosmetic side effects and affect menstrual cycles, fertility, and bone health in women with epilepsy.

Parents often claim to use more home safety measures than they actually do.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Antiandrogen therapy helps treat genetic hair loss.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

No significant link between CAG repeat numbers and female pattern hair loss in Han Chinese population.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Bardet-Biedl syndrome may include under-recognized skin problems related to its metabolic disturbances.